Orexo AB (ORX.ST)
Makes medications for opioid addiction, cancer pain, and overdose emergencies.
14.50-0.04%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-29.3%
The outlook
Orexo trades near its 52-week low, well below both its 50- and 200-day moving averages, signaling a weak recent trend. Analyst coverage shows an average price target about 83% above the current level, though the overall sentiment leans bearish. The stock sits near the bottom of its yearly range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +83% vs current price
Market cap
—
52-wk high
43.40
52-wk low
14.04
50-day avg
20.55
200-day avg
24.50
Trailing P/E
—